Alethea Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,315
| Closed | -$425K | – | 37 |
|
|
2023
Q3 | $425K | Buy |
+7,315
| New | +$425K | 0.52% | 17 |
|
|
2023
Q2 | – | Sell |
-8,965
| Closed | -$621K | – | 56 |
|
|
2023
Q1 | $621K | Buy |
+8,965
| New | +$621K | 0.66% | 17 |
|
|
2020
Q4 | – | Sell |
-10,487
| Closed | -$632K | – | 74 |
|
|
2020
Q3 | $632K | Sell |
10,487
-15,306
| -59% | -$922K | 0.43% | 31 |
|
|
2020
Q2 | $1.52M | Buy |
25,793
+4,571
| +22% | +$269K | 0.89% | 8 |
|
|
2020
Q1 | $1.18M | Buy |
+21,222
| New | +$1.18M | 0.77% | 11 |
|
|
2019
Q1 | – | Sell |
-26,873
| Closed | -$1.4M | – | 76 |
|
|
2018
Q4 | $1.4M | Buy |
+26,873
| New | +$1.4M | 2.03% | 12 |
|
|
2018
Q2 | – | Sell |
-7,752
| Closed | -$490K | – | 66 |
|
|
2018
Q1 | $490K | Buy |
+7,752
| New | +$490K | 0.66% | 40 |
|
|
2017
Q3 | – | Sell |
-27,038
| Closed | -$1.51M | – | 74 |
|
|
2017
Q2 | $1.51M | Buy |
+27,038
| New | +$1.51M | 1.71% | 20 |
|
|
2017
Q1 | – | Sell |
-27,392
| Closed | -$1.6M | – | 73 |
|
|
2016
Q4 | $1.6M | Buy |
27,392
+11,109
| +68% | +$649K | 2.02% | 17 |
|
|
2016
Q3 | $878K | Buy |
+16,283
| New | +$878K | 1.22% | 28 |
|
|
2015
Q4 | – | Sell |
-8,190
| Closed | -$485K | – | 68 |
|
|
2015
Q3 | $485K | Sell |
8,190
-2,025
| -20% | -$120K | 0.74% | 33 |
|
|
2015
Q2 | $680K | Buy |
+10,215
| New | +$680K | 1.04% | 20 |
|